P3 Health Partners Stock Probability of Future Stock Price Finishing Over 25.14
| PIII Stock | USD 0.25 0.01 4.17% |
PIII |
P3 Health Target Price Odds to finish over 25.14
The tendency of PIII Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 25.14 or more in 90 days |
| 0.25 | 90 days | 25.14 | close to zero percent |
Based on a normal probability distribution, the odds of P3 Health to move over $ 25.14 or more in 90 days from now is close to zero percent (This P3 Health Partners probability density function shows the probability of PIII Stock to fall within a particular range of prices over 90 days) . Probability of P3 Health Partners price to stay between its current price of $ 0.25 and $ 25.14 at the end of the 90-day period is about 92.07 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.0 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, P3 Health will likely underperform. Additionally P3 Health Partners has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. P3 Health Price Density |
| Price |
Predictive Modules for P3 Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as P3 Health Partners. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.P3 Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. P3 Health is not an exception. The market had few large corrections towards the P3 Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold P3 Health Partners, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of P3 Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.87 | |
β | Beta against Dow Jones | 2.00 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | -0.09 |
P3 Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of P3 Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for P3 Health Partners can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| P3 Health Partners generated a negative expected return over the last 90 days | |
| P3 Health Partners has high historical volatility and very poor performance | |
| P3 Health Partners has some characteristics of a very speculative penny stock | |
| P3 Health Partners has high likelihood to experience some financial distress in the next 2 years | |
| P3 Health Partners currently holds 121.94 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. P3 Health Partners has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.27 B. Net Loss for the year was (57.77 M) with loss before overhead, payroll, taxes, and interest of (7.75 M). | |
| P3 Health Partners currently holds about 63.15 M in cash with (76.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| P3 Health Partners has a frail financial position based on the latest SEC disclosures | |
| Roughly 23.0% of P3 Health outstanding shares are owned by corporate insiders | |
| Latest headline from businesswire.com: P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference |
P3 Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PIII Stock often depends not only on the future outlook of the current and potential P3 Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. P3 Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 294.6 M | |
| Cash And Short Term Investments | 36.3 M |
P3 Health Technical Analysis
P3 Health's future price can be derived by breaking down and analyzing its technical indicators over time. PIII Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of P3 Health Partners. In general, you should focus on analyzing PIII Stock price patterns and their correlations with different microeconomic environments and drivers.
P3 Health Predictive Forecast Models
P3 Health's time-series forecasting models is one of many P3 Health's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary P3 Health's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about P3 Health Partners
Checking the ongoing alerts about P3 Health for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for P3 Health Partners help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| P3 Health Partners generated a negative expected return over the last 90 days | |
| P3 Health Partners has high historical volatility and very poor performance | |
| P3 Health Partners has some characteristics of a very speculative penny stock | |
| P3 Health Partners has high likelihood to experience some financial distress in the next 2 years | |
| P3 Health Partners currently holds 121.94 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. P3 Health Partners has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.27 B. Net Loss for the year was (57.77 M) with loss before overhead, payroll, taxes, and interest of (7.75 M). | |
| P3 Health Partners currently holds about 63.15 M in cash with (76.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| P3 Health Partners has a frail financial position based on the latest SEC disclosures | |
| Roughly 23.0% of P3 Health outstanding shares are owned by corporate insiders | |
| Latest headline from businesswire.com: P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference |
Check out P3 Health Backtesting, P3 Health Valuation, P3 Health Correlation, P3 Health Hype Analysis, P3 Health Volatility, P3 Health History as well as P3 Health Performance. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of P3 Health. If investors know PIII will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.86) | Revenue Per Share 11.552 | Quarterly Revenue Growth 0.152 | Return On Assets (0.12) | Return On Equity (0.41) |
The market value of P3 Health Partners is measured differently than its book value, which is the value of PIII that is recorded on the company's balance sheet. Investors also form their own opinion of P3 Health's value that differs from its market value or its book value, called intrinsic value, which is P3 Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because P3 Health's market value can be influenced by many factors that don't directly affect P3 Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between P3 Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if P3 Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.